A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]
- PMID: 16595003
- PMCID: PMC1481554
- DOI: 10.1186/1471-2393-6-10
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]
Abstract
Background: Prenatal micronutrient combinations with high iron content are associated with high rates of gastrointestinal symptoms. This coupled with nausea and vomiting of pregnancy results in women often discontinuing their multivitamins. A new prescription supplement (PregVit) that separates iron from calcium in two tablets--morning and evening, has lower elemental iron content (35 mg), but results in similar extent of iron absorption when compared to another supplement containing (60 mg) of elemental iron (Materna). The objectives of this study were to compare tolerability and compliance with PregVit vs. a supplement with high iron content (Materna), in pregnant women.
Methods: Randomized, crossover open labeled study in 135 pregnant women attending outpatient clinics in Ontario and Quebec.
Results: Use of PregVit was associated with a 30% reduction in constipation rate as compared to Materna. Both products demonstrated similar compliance rates. Compliance of Materna was negatively associated with the severity of nausea and vomiting of pregnancy. No such correlation was found for PregVvit.
Conclusion: PregVit, a supplement with lower iron content (35 mg), has significantly decreased constipation rates as compared to 60 mg iron--Materna and has similar compliance rates. High iron content in multivitamin supplements is associated with adverse effects in pregnancy.
Similar articles
-
Effect of iron content on the tolerability of prenatal multivitamins in pregnancy.BMC Pregnancy Childbirth. 2008 May 15;8:17. doi: 10.1186/1471-2393-8-17. BMC Pregnancy Childbirth. 2008. PMID: 18482454 Free PMC article. Clinical Trial.
-
Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions.J Obstet Gynaecol. 2009 Oct;29(7):594-8. doi: 10.1080/01443610903114527. J Obstet Gynaecol. 2009. PMID: 19757261 Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.Cochrane Database Syst Rev. 2015 Jun 19;2015(6):CD011158. doi: 10.1002/14651858.CD011158.pub2. Cochrane Database Syst Rev. 2015. PMID: 26091836 Free PMC article. Review.
-
Micronutrient supplementation in pregnant women with HIV infection.Cochrane Database Syst Rev. 2012 Mar 14;(3):CD009755. doi: 10.1002/14651858.CD009755. Cochrane Database Syst Rev. 2012. PMID: 22419344 Review.
Cited by
-
Multiple-micronutrient supplementation for women during pregnancy.Cochrane Database Syst Rev. 2019 Mar 14;3(3):CD004905. doi: 10.1002/14651858.CD004905.pub6. Cochrane Database Syst Rev. 2019. PMID: 30873598 Free PMC article.
-
Factors influencing maternal nutrition practices in a large scale maternal, newborn and child health program in Bangladesh.PLoS One. 2017 Jul 10;12(7):e0179873. doi: 10.1371/journal.pone.0179873. eCollection 2017. PLoS One. 2017. PMID: 28692689 Free PMC article.
-
Multiple-micronutrient supplementation for women during pregnancy.Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD004905. doi: 10.1002/14651858.CD004905.pub6. PMID: 28407219 Free PMC article. Updated. Review.
-
Multiple-micronutrient supplementation for women during pregnancy.Cochrane Database Syst Rev. 2015 Nov 1;2015(11):CD004905. doi: 10.1002/14651858.CD004905.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Apr 13;4:CD004905. doi: 10.1002/14651858.CD004905.pub5. PMID: 26522344 Free PMC article. Updated. Review.
-
Intermittent oral iron supplementation during pregnancy.Cochrane Database Syst Rev. 2015 Oct 19;2015(10):CD009997. doi: 10.1002/14651858.CD009997.pub2. Cochrane Database Syst Rev. 2015. PMID: 26482110 Free PMC article. Review.
References
-
- National Research Council (U.S.) Subcommittee on the Tenth Edition of the RDAs. Recommended dietary allowances/Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Sciences, National Research Council. Washington, D.C: National Academy Press; 1989.
-
- Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine . Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, D.C: National Academy Press; 2002. pp. 770–73. - PubMed
-
- Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832–35. - PubMed
-
- Wald N, Hack Shaw A. Folic acid and prevention of neural-tube defects. Lancet. 1992;350:605. - PubMed
LinkOut - more resources
Full Text Sources